| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VOR | VOR BIOPHARMA INC | $785.15M | $14.49 | $35.80 | 147.07% | Strong Buy | 5 | N/A | N/A | N/A | -18.65% | |||
| VKTX | VIKING THERAPEUTICS INC | $3.53B | $30.38 | $104.00 | 242.33% | Strong Buy | 4 | N/A | N/A | -34.82% | -28.73% | |||
| CCCC | C4 THERAPEUTICS INC | $458.85M | $4.15 | $16.33 | 293.57% | Strong Buy | 3 | -20.23% | N/A | -52.96% | -37.72% | |||
| AKTS | AKTIS ONCOLOGY INC | $1.29B | $24.09 | $35.00 | 45.29% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| PEPG | PEPGEN INC | $123.81M | $1.79 | $9.25 | 416.76% | Strong Buy | 4 | N/A | N/A | -44.94% | -38.52% | |||
| RACE | FERRARI NV | $63.92B | $362.13 | $456.00 | 25.92% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| CRVS | CORVUS PHARMACEUTICALS INC | $1.00B | $11.91 | $34.00 | 185.47% | Strong Buy | 5 | N/A | N/A | -9.80% | -9.32% | |||
| BNTX | BIONTECH SE | $21.81B | $90.89 | $128.82 | 41.73% | Strong Buy | 11 | -6.97% | N/A | -4.27% | -3.79% | |||
| SAIL | SAILPOINT INC | $7.56B | $13.33 | $19.80 | 48.54% | Strong Buy | 15 | 11.46% | N/A | 3.65% | 3.32% | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $248.11M | $8.60 | $11.50 | 33.72% | Strong Buy | 7 | N/A | N/A | N/A | N/A | |||
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $214.03M | $7.53 | $19.00 | 152.32% | Strong Buy | 4 | -14.47% | N/A | -30.88% | -24.08% | |||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $1.14B | $4.26 | $6.68 | 56.88% | Strong Buy | 6 | N/A | N/A | N/A | N/A | |||
| EQT | EQT CORP | $31.72B | $50.72 | $71.08 | 40.14% | Strong Buy | 13 | -0.57% | 0.00% | 13.12% | 7.90% | |||
| REAX | REAL BROKERAGE INC | $370.44M | $1.76 | $4.86 | 176.31% | Strong Buy | 4 | 16.36% | N/A | 3.27% | 1.37% | |||
| GT | GOODYEAR TIRE & RUBBER CO | $1.78B | $6.19 | $9.00 | 45.40% | Strong Buy | 4 | 2.09% | N/A | 16.46% | 2.68% | |||
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $605.61M | $7.56 | $24.75 | 227.38% | Strong Buy | 4 | N/A | N/A | -43.59% | -38.85% | |||
| SLDB | SOLID BIOSCIENCES INC | $820.09M | $8.33 | $18.71 | 124.66% | Strong Buy | 7 | N/A | N/A | -0.04% | -0.04% | |||
| PCVX | VAXCYTE INC | $7.43B | $51.44 | $105.00 | 104.12% | Strong Buy | 3 | N/A | N/A | -9.72% | -8.70% | |||
| CGEM | CULLINAN THERAPEUTICS INC | $923.71M | $15.03 | $33.60 | 123.55% | Strong Buy | 5 | N/A | N/A | -47.25% | -42.93% | |||
| ORIC | ORIC PHARMACEUTICALS INC | $878.86M | $8.49 | $20.00 | 135.57% | Strong Buy | 4 | N/A | N/A | -44.34% | -42.19% | |||
| XE | X-ENERGY INC | $6.20B | $21.56 | $39.57 | 83.54% | Strong Buy | 7 | N/A | N/A | N/A | -9.78% | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $336.44M | $2.95 | $12.71 | 330.98% | Strong Buy | 7 | -10.14% | N/A | -34.82% | -29.45% |